HG102
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for HG102, covering 2024-01-16 to 2024-01-16. Get the full timeline:
Most recent: Clinical Trial Update: Evaluate the Safety and Efficacy of HG102 as Compared to Botox® in Subject With Moderate to Severe Glabellar Lines [Phase 3]